Establish your trading edge with a set of smart tools for serious trades.
Upgrade Account
stock
Protalix Biotherapeutics Inc
NYSE MKT | PLX
2.60
USD
+0.01 (+0.39%)
AT CLOSE (AS OF Apr 3, 2025)
$202M
MARKET CAP
64.75
P/E Ratio
0.04
EPS
$2.8
52 Week High
$0.82
52 Week Low
LIFE SCIENCES
Sector
PLX Chart
1D
Area
Trade Smarter
Take control of your trading journey with a set of smart tools for serious trades
PLX Technicals
PLX Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $29M |
| Total Revenue | $53M |
| Cost Of Revenue | $24M |
| Costof Goods And Services Sold | $90K |
| Operating Income | $3.9M |
| Selling General And Administrative | $12M |
| Research And Development | $13M |
| Operating Expenses | $34M |
| Investment Income Net | - |
| Net Interest Income | $237K |
| Interest Income | $1.3M |
| Interest Expense | $1.1M |
| Non Interest Income | -$307K |
| Other Non Operating Income | $237K |
| Depreciation | $1.3M |
| Depreciation And Amortization | $1.3M |
| Income Before Tax | $4.2M |
| Income Tax Expense | $1.2M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $2.9M |
| Comprehensive Income Net Of Tax | $2.9M |
| Ebit | $3.9M |
| Ebitda | $6.5M |
| Net Income | $2.9M |
Revenue & Profitability
Earnings Performance
PLX Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $73M |
| Total Current Assets | $60M |
| Cash And Cash Equivalents At Carrying Value | $20M |
| Cash And Short Term Investments | $20M |
| Inventory | $21M |
| Current Net Receivables | $2.9M |
| Total Non Current Assets | $13M |
| Property Plant Equipment | $4.6M |
| Accumulated Depreciation Amortization Ppe | $36M |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $15M |
| Other Current Assets | $1.1M |
| Other Non Current Assets | - |
| Total Liabilities | $30M |
| Total Current Liabilities | $26M |
| Current Accounts Payable | $4.5M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.5M |
| Total Non Current Liabilities | $4.6M |
| Capital Lease Obligations | $5.5M |
| Long Term Debt | - |
| Current Long Term Debt | $0 |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $5.5M |
| Other Current Liabilities | $16M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $43M |
| Treasury Stock | - |
| Retained Earnings | -$378M |
| Common Stock | $76K |
| Common Stock Shares Outstanding | $76M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $8.7M |
| Payments For Operating Activities | $3.2M |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | $696K |
| Change In Operating Assets | -$119K |
| Depreciation Depletion And Amortization | $1.3M |
| Capital Expenditures | $1.3M |
| Change In Receivables | -$2.3M |
| Change In Inventory | $2.2M |
| Profit Loss | $2.9M |
| Cashflow From Investment | $4.2M |
| Cashflow From Financing | -$17M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | $3.6M |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | $0 |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $2.9M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $29M |
| Total Revenue | $53M |
| Cost Of Revenue | $24M |
| Costof Goods And Services Sold | $90K |
| Operating Income | $3.9M |
| Selling General And Administrative | $12M |
| Research And Development | $13M |
| Operating Expenses | $34M |
| Investment Income Net | - |
| Net Interest Income | $237K |
| Interest Income | $1.3M |
| Interest Expense | $1.1M |
| Non Interest Income | -$307K |
| Other Non Operating Income | $237K |
| Depreciation | $1.3M |
| Depreciation And Amortization | $1.3M |
| Income Before Tax | $4.2M |
| Income Tax Expense | $1.2M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $2.9M |
| Comprehensive Income Net Of Tax | $2.9M |
| Ebit | $3.9M |
| Ebitda | $6.5M |
| Net Income | $2.9M |
PLX Profile
Protalix Biotherapeutics Inc Profile
Sector: LIFE SCIENCES
Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, the rest of Latin America and internationally. The company is headquartered in Karmiel, Israel.
DMN 13.04%
$0.0156
NVDA -6.59%
$103.1408
F -5.96%
$9.545
LCID -2.30%
$2.3448
PTIX 91.50%
$0.4347
ICCT 111.59%
$4.38
LGMK -15.96%
$0.0158
TSLA -5.47%
$267.28
MGOL -20.43%
$0.37
NIVF 4.41%
$0.615
DGLY 6.97%
$0.0353
ALTM 0.00%
$5.84
BAC -11.39%
$37.0849
OSRH 65.99%
$2.4401
PLTR -3.73%
$84.185
LILM -36.97%
$0.052
AMZN -8.86%
$178.6365
AAPL -9.86%
$201.81
APVO 41.36%
$1.9507
AAL -10.25%
$9.505
BON -12.81%
$0.0633
NKE -14.59%
$55.485
BTE -10.54%
$1.995
SOFI -13.56%
$10.6402
DNN -4.23%
$1.245
INTC -0.32%
$21.98
GNPX 38.98%
$0.41
MULN -23.30%
$0.079
HOOD -10.54%
$38.1811
LYT -16.78%
$0.0982
BBD 2.93%
$2.285
MRM 74.84%
$0.6469
STSS -7.74%
$0.0274
PMAX 1.21%
$0.4524
BTG -0.33%
$2.9105
JYD 21.48%
$0.4197
VALE -3.32%
$9.755
WBD -12.78%
$9.21
ABEV 2.54%
$2.42
SNAP -9.22%
$8.0614
PLUG -8.33%
$1.21
SMCI -7.99%
$32.285
T 1.81%
$28.6482
RIG -12.82%
$2.755
JBLU -17.36%
$4.165
NKLA -28.74%
$0.183
CCL -13.21%
$17.375
ITUB 2.71%
$5.68
PFE -1.07%
$24.435
ATPC -1.94%
$1.265
TIVC 49.51%
$4.8592
RIVN -8.09%
$11.48
GOOGL -3.75%
$151.155
SLB -7.02%
$39.2299
MU -14.48%
$75.77
IQ -4.57%
$2.09
C -11.97%
$63.17
QBTS -2.72%
$7.14
AGNC -1.58%
$9.33
NIO -1.71%
$3.735
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
META -8.30%
$535.49
UAA -19.49%
$5.3136
CSCO -6.83%
$57.595
CLF -16.78%
$7.265
HBAN -11.11%
$13.52
AVGO -9.83%
$155.175
VRN -5.75%
$6.2961
ET -5.78%
$17.835
HPE -13.97%
$13.8687
WMT -2.88%
$87.1713
AMCR -2.37%
$9.5676
BABA -0.62%
$128.98
STLA -8.83%
$10.275
RGTI -3.65%
$8.18
ERIC -3.40%
$7.525
FCX -11.75%
$33.71
CX -2.43%
$5.5518
VFC -28.68%
$11.6888
VZ 2.03%
$45.6469
GAP -20.26%
$17.845
CRWV
-13.00%
$53.3815
NOK -6.07%
$5.025
FSM -1.96%
$6.1178
TSM -6.87%
$158.69
BCS -8.74%
$14.365
GOOG -3.39%
$153.4723
LYG 0.79%
$3.84
MARA -8.78%
$11.33
VHAI 0.00%
$0.0012
NCLH -15.96%
$16.3871
MSFT -2.00%
$374.48
GRAB -7.48%
$4.265
ACHR -3.61%
$6.94
CNTM 13.14%
$0.8466
AMD 0.18%
$102.96
PINS -12.72%
$27.39
W -25.89%
$24.9902
KEY -12.29%
$14.095
DMN 13.04%
$0.0156
NVDA -6.59%
$103.1408
F -5.96%
$9.545
LCID -2.30%
$2.3448
PTIX 91.50%
$0.4347
ICCT 111.59%
$4.38
LGMK -15.96%
$0.0158
TSLA -5.47%
$267.28
MGOL -20.43%
$0.37
NIVF 4.41%
$0.615
DGLY 6.97%
$0.0353
ALTM 0.00%
$5.84
BAC -11.39%
$37.0849
OSRH 65.99%
$2.4401
PLTR -3.73%
$84.185
LILM -36.97%
$0.052
AMZN -8.86%
$178.6365
AAPL -9.86%
$201.81
APVO 41.36%
$1.9507
AAL -10.25%
$9.505
BON -12.81%
$0.0633
NKE -14.59%
$55.485
BTE -10.54%
$1.995
SOFI -13.56%
$10.6402
DNN -4.23%
$1.245
INTC -0.32%
$21.98
GNPX 38.98%
$0.41
MULN -23.30%
$0.079
HOOD -10.54%
$38.1811
LYT -16.78%
$0.0982
BBD 2.93%
$2.285
MRM 74.84%
$0.6469
STSS -7.74%
$0.0274
PMAX 1.21%
$0.4524
BTG -0.33%
$2.9105
JYD 21.48%
$0.4197
VALE -3.32%
$9.755
WBD -12.78%
$9.21
ABEV 2.54%
$2.42
SNAP -9.22%
$8.0614
PLUG -8.33%
$1.21
SMCI -7.99%
$32.285
T 1.81%
$28.6482
RIG -12.82%
$2.755
JBLU -17.36%
$4.165
NKLA -28.74%
$0.183
CCL -13.21%
$17.375
ITUB 2.71%
$5.68
PFE -1.07%
$24.435
ATPC -1.94%
$1.265
TIVC 49.51%
$4.8592
RIVN -8.09%
$11.48
GOOGL -3.75%
$151.155
SLB -7.02%
$39.2299
MU -14.48%
$75.77
IQ -4.57%
$2.09
C -11.97%
$63.17
QBTS -2.72%
$7.14
AGNC -1.58%
$9.33
NIO -1.71%
$3.735
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
META -8.30%
$535.49
UAA -19.49%
$5.3136
CSCO -6.83%
$57.595
CLF -16.78%
$7.265
HBAN -11.11%
$13.52
AVGO -9.83%
$155.175
VRN -5.75%
$6.2961
ET -5.78%
$17.835
HPE -13.97%
$13.8687
WMT -2.88%
$87.1713
AMCR -2.37%
$9.5676
BABA -0.62%
$128.98
STLA -8.83%
$10.275
RGTI -3.65%
$8.18
ERIC -3.40%
$7.525
FCX -11.75%
$33.71
CX -2.43%
$5.5518
VFC -28.68%
$11.6888
VZ 2.03%
$45.6469
GAP -20.26%
$17.845
CRWV
-13.00%
$53.3815
NOK -6.07%
$5.025
FSM -1.96%
$6.1178
TSM -6.87%
$158.69
BCS -8.74%
$14.365
GOOG -3.39%
$153.4723
LYG 0.79%
$3.84
MARA -8.78%
$11.33
VHAI 0.00%
$0.0012
NCLH -15.96%
$16.3871
MSFT -2.00%
$374.48
GRAB -7.48%
$4.265
ACHR -3.61%
$6.94
CNTM 13.14%
$0.8466
AMD 0.18%
$102.96
PINS -12.72%
$27.39
W -25.89%
$24.9902
KEY -12.29%
$14.095
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.